Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes

Nutrition Journal

Benoît Lamarche¹  Valéry Lemelin²  Jean-Charles Hogue¹  André J Tremblay¹  Patrick Couture¹  Marie-Ève Labonté¹ 

[1] Institute of Nutrition and Functional Foods, Laval University, 2440 boul. Hochelaga, Québec (Qc) G1V 0A6, Canada;Department of Gastroenterology, Laval University Hospital Research Center, 2705, boul. Laurier, Québec (Qc) G1V 4G2, Canada

关键词: Type 2 diabetes;    Duodenum;    Placebo-controlled;    n-3 supplementation;    Inflammatory gene expression;    Signal transducer and activator of transcription 3 (STAT3);    Docosahexaenoic acid (DHA);    Eicosapentaenoic acid (EPA);   

Others  :  806233
DOI  :  10.1186/1475-2891-12-98

 received in 2013-02-20, accepted in 2013-07-09,  发布年份 2013

【 摘 要 】

Background

The extent to which long-chain omega-3 polyunsaturated fatty acids (LCn-3PUFA) from fish oil such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) exert their anti-inflammatory effects by down-regulating intestinal inflammation in humans is unknown. We investigated the impact of LCn-3PUFA supplementation on inflammatory gene expression in the duodenum of obese patients with type 2 diabetes.

Findings

This placebo-controlled randomized crossover study included 12 men with type 2 diabetes. After a 4-week run-in period, patients received in a random sequence 5 g/d of fish oil (providing 3 g of EPA + DHA) and a placebo (corn and soybean oil) for 8 weeks each. The two treatment phases were separated by a 12-week washout period. Gene expression was assessed by real-time polymerase chain reaction in duodenal biopsy samples obtained in the fasted state at the end of each treatment phase. Intestinal mRNA expression levels of interleukin (IL)-6 and tumor-necrosis factor (TNF)-α were hardly detectable after either treatment (<100 copies/10⁵ copies of the reference gene ATP5o). Intestinal mRNA expression of IL-18 and of the transcription factor signal transducer and activator of transcription 3 (STAT3) was higher (>5000 copies/10⁵ copies ATP5o) but still relatively low. EPA + DHA supplementation had no impact on any of these levels (all P ≥ 0.73).

Conclusions

These data suggest that duodenal cells gene expression of pro-inflammatory cytokines is low in patients with type 2 diabetes and not affected by EPA + DHA supplementation. Further studies are warranted to determine if inflammatory gene expression in other tissues surrounding the intestine is modulated by EPA + DHA supplementation.

Trial registration

ClinicalTrials.gov ID: NCT01449773

【 授权许可】

   
2013 Labonté et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Pradhan A: Obesity, metalic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutr Rev 2007, 65:S152-S156.
• [2]Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased Adipose-tissue expression of tumor-necrosis-factor-alpha in human obesity and insulin-resistance. J Clin Invest 1995, 95:2409-2415.
• [3]Gonzalez-Periz A, Claria J: Resolution of adipose tissue inflammation. ScientificWorldJournal 2010, 10:832-856.
• [4]Ding S, Lund PK: Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care 2011, 14:328-333.
• [5]Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LCPG, Geleijnse JM, Muller M, Afman LA: Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 2009, 90:415-424.
• [6]Hsueh HW, Zhou Z, Whelan J, Allen KGD, Moustaid-Moussa N, Kim H, Claycombe KJ: Stearidonic and Eicosapentaenoic acids inhibit interleukin-6 expression in ob/ob mouse adipose stem cells via toll-like receptor-2-mediated pathways. J Nutr 2011, 141:1260-1266.
• [7]Kopecky J, Rossmeisl M, Flachs P, Kuda O, Brauner P, Jilkova Z, Stankova B, Tvrzicka E, Bryhn M: n-3 PUFA: bioavailability and modulation of adipose tissue function. Proc Nutr Soc 2009, 68:361-369.
• [8]Myhrstad MCW, Retterstol K, Telle-Hansen VH, Ottestad I, Halvorsen B, Holven KB, Ulven SM: Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors. Inflamm Res 2011, 60:309-319.
• [9]Genuth S, Alberti KGMM, Bennett P, Buse J, DeFronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
• [10]Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkind BM, Schonfeld G, Jacobs D, Frantz ID: Lipoprotein-cholesterol distributions in selected north-American populations - lipid research clinics program prevalence study. Circulation 1980, 61:302-315.
• [11]NCEP Expert Panel: Executive Summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497.
• [12]Goulet J, Nadeau G, Lapointe A, Lamarche B, Lemieux S: Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Nutr J 2004, 3:13. BioMed Central Full Text
• [13]Frasure-Smith N, Lesperance F, Julien P: Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 2004, 55:891-896.
• [14]Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, Seidah NG, Davis HR, Couture P: Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. J Lipid Res 2011, 52:558-565.
• [15]Luu-The V, Paquet N, Calvo E, Cumps J: Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques 2005, 38:287-293.
• [16]Warrington JA, Nair A, Mahadevappa M, Tsyganskaya M: Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes. Physiol Genomics 2000, 2:143-147.
• [17]Olivier I, Theodorou V, Valet P, Castan-Laurell I, Guillou H, Bertrand-Michel J, Cartier C, Bezirard V, Ducroc R, Segain JP, Portier G, Kirzin S, Moreau J, Duffas JP, Ferrier L, Eutamene H: Is Crohn's creeping Fat an adipose tissue? Inflamm Bowel Dis 2011, 17:747-757.
• [18]Desreumaux P, Ernst O, Geboes K, Gambiez L, Berrebi D, Muller-Alouf H, Hafraoui S, Emilie D, Ectors N, Peuchmaur M, Cortot A, Capron M, Auwerx J, Colombel JF: Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999, 117:73-81.
• [19]Kleemann R, Scott FW, Worz-Pagenstert U, Ratnayake WMN, Kolb H: Impact of dietary fat on Th1/Tk2 cytokine gene expression in the pancreas and gut of diabetes-prone BB rats. J Autoimmun 1998, 11:97-103.
• [20]van Schothorst EM, Flachs P, Franssen-van Hal NLW, Kuda O, Bunschoten A, Molthoff J, Vink C, Hooiveld GJEJ, Kopecky J, Keijer J: Induction of lipid oxidation by polyunsaturated fatty acids of marine origin in small intestine of mice fed a high-fat diet. BMC Genomics 2009, 10:110. BioMed Central Full Text
• [21]Calder PC: Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 2008, 52:885-897.
• [22]Pot GK, Geelen A, Majsak-Newman G, Harvey LJ, Nagengast FM, Witteman BJM, van de Meeberg PC, Hart AR, Schaafsma G, Lund EK, Rijkers GI, Kampman E: Increased Consumption of fatty and lean fish reduces serum C-reactive protein concentrations but Not inflammation markers in feces and in colonic biopsies. J Nutr 2010, 140:371-376.